Parent, Guarantor, Non-Guarantor Unaudited Consolidating Financial Statements (Unaudited) - Consolidated Statement of Cash Flows (Detail) - USD ($)
|
3 Months Ended |
12 Months Ended |
Dec. 31, 2018 |
Sep. 30, 2018 |
Jun. 30, 2018 |
Mar. 31, 2018 |
Dec. 31, 2017 |
Sep. 30, 2017 |
Jun. 30, 2017 |
Mar. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ (43,073,000)
|
$ (70,951,000)
|
$ (22,877,000)
|
$ (28,796,000)
|
$ (28,693,000)
|
$ (20,311,000)
|
$ (29,888,000)
|
$ (39,809,000)
|
$ (165,697,000)
|
$ (118,701,000)
|
$ (230,814,000)
|
Adjustments to reconcile net income (loss): |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
107,545,000
|
122,373,000
|
139,795,000
|
(Gain) loss on debt modification |
|
|
|
|
|
|
|
|
|
|
1,088,000
|
Accretion on contingent consideration |
|
|
|
|
|
|
|
|
0
|
0
|
419,000
|
(Gain) loss on debt modification |
|
|
|
|
|
|
|
|
9,789,000
|
0
|
|
Gain (loss) on disposition of assets, net |
|
|
|
|
|
|
|
|
1,724,000
|
2,851,000
|
1,613,000
|
Deferred tax expense (benefit) |
|
|
|
|
|
|
|
|
(429,000)
|
(224,000)
|
69,062,000
|
Loss on impairment |
|
|
|
|
|
|
|
|
50,698,000
|
0
|
0
|
Equity in net earnings of subsidiaries |
|
|
|
|
|
|
|
|
7,538,000
|
0
|
0
|
Provision for reduction in carrying value of certain assets |
|
|
|
|
|
|
|
|
0
|
1,938,000
|
0
|
Expenses not requiring cash |
|
|
|
|
|
|
|
|
5,151,000
|
4,251,000
|
2,518,000
|
Equity in net earnings (losses) of subsidiaries |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Accounts and notes receivable |
|
|
|
|
|
|
|
|
(15,235,000)
|
(9,628,000)
|
60,391,000
|
Rig materials and supplies |
|
|
|
|
|
|
|
|
249,000
|
4,710,000
|
(1,752,000)
|
Other current assets |
|
|
|
|
|
|
|
|
(10,860,000)
|
(1,319,000)
|
2,140,000
|
Other non-current assets |
|
|
|
|
|
|
|
|
13,019,000
|
8,658,000
|
3,897,000
|
Accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
(9,489,000)
|
(8,714,000)
|
(19,494,000)
|
Accrued income taxes |
|
|
|
|
|
|
|
|
(1,264,000)
|
538,000
|
(6,422,000)
|
Net cash provided by (used in) operating activities |
|
|
|
|
|
|
|
|
(17,050,000)
|
6,733,000
|
22,441,000
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
|
|
|
|
|
|
(70,567,000)
|
(54,533,000)
|
(28,954,000)
|
Proceeds from the sale of assets |
|
|
|
|
|
|
|
|
1,353,000
|
403,000
|
2,441,000
|
Net cash provided by (used in) investing activities |
|
|
|
|
|
|
|
|
(69,214,000)
|
(54,130,000)
|
(26,513,000)
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the issuance of common stock |
|
|
|
|
|
|
|
|
0
|
25,200,000
|
0
|
Proceeds from the issuance of convertible preferred stock |
|
|
|
|
|
|
|
|
0
|
50,000,000
|
0
|
Payment of equity issuance costs |
|
|
|
|
|
|
|
|
0
|
(2,864,000)
|
0
|
Proceeds from borrowing under DIP facility |
|
|
|
|
|
|
|
|
10,000,000
|
0
|
0
|
Payment of DIP facility costs |
|
|
|
|
|
|
|
|
(975,000)
|
0
|
0
|
Convertible preferred stock dividend |
|
|
|
|
|
|
|
|
(3,625,000)
|
(2,145,000)
|
0
|
Payments of debt issuance costs |
|
|
|
|
|
|
|
|
(1,443,000)
|
0
|
0
|
Payment for noncontrolling interest |
|
|
|
|
|
|
|
|
0
|
0
|
(3,375,000)
|
Payment of contingent consideration |
|
|
|
|
|
|
|
|
0
|
0
|
(6,000,000)
|
Shares surrendered in lieu of tax |
|
|
|
|
|
|
|
|
(251,000)
|
(936,000)
|
(1,156,000)
|
Intercompany advances, net |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Net cash provided by (used in) financing activities |
|
|
|
|
|
|
|
|
3,706,000
|
69,255,000
|
(10,531,000)
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
(82,558,000)
|
21,858,000
|
(14,603,000)
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|
141,549,000
|
|
|
|
119,691,000
|
141,549,000
|
119,691,000
|
134,294,000
|
Cash, cash equivalents and restricted cash at end of period |
58,991,000
|
|
|
|
141,549,000
|
|
|
|
58,991,000
|
141,549,000
|
119,691,000
|
Reportable Legal Entities | Parent |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
(165,697,000)
|
(118,701,000)
|
(230,814,000)
|
Adjustments to reconcile net income (loss): |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
(Gain) loss on debt modification |
|
|
|
|
|
|
|
|
|
|
1,088,000
|
Accretion on contingent consideration |
|
|
|
|
|
|
|
|
|
|
0
|
Gain (loss) on disposition of assets, net |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Deferred tax expense (benefit) |
|
|
|
|
|
|
|
|
13,226,000
|
4,785,000
|
47,971,000
|
Loss on impairment |
|
|
|
|
|
|
|
|
0
|
|
|
Equity in net earnings of subsidiaries |
|
|
|
|
|
|
|
|
7,538,000
|
|
|
Provision for reduction in carrying value of certain assets |
|
|
|
|
|
|
|
|
|
0
|
|
Expenses not requiring cash |
|
|
|
|
|
|
|
|
4,526,000
|
5,651,000
|
9,545,000
|
Equity in net earnings (losses) of subsidiaries |
|
|
|
|
|
|
|
|
87,548,000
|
40,752,000
|
94,469,000
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Accounts and notes receivable |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Rig materials and supplies |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Other current assets |
|
|
|
|
|
|
|
|
(8,088,000)
|
(50,296,000)
|
50,296,000
|
Other non-current assets |
|
|
|
|
|
|
|
|
1,042,000
|
361,000
|
(299,000)
|
Accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
(63,054,000)
|
(41,885,000)
|
(121,016,000)
|
Accrued income taxes |
|
|
|
|
|
|
|
|
11,611,000
|
79,319,000
|
(10,381,000)
|
Net cash provided by (used in) operating activities |
|
|
|
|
|
|
|
|
(111,348,000)
|
(80,014,000)
|
(159,141,000)
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Proceeds from the sale of assets |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Net cash provided by (used in) investing activities |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the issuance of common stock |
|
|
|
|
|
|
|
|
|
25,200,000
|
|
Proceeds from the issuance of convertible preferred stock |
|
|
|
|
|
|
|
|
|
50,000,000
|
|
Payment of equity issuance costs |
|
|
|
|
|
|
|
|
|
(2,864,000)
|
|
Proceeds from borrowing under DIP facility |
|
|
|
|
|
|
|
|
10,000,000
|
|
|
Payment of DIP facility costs |
|
|
|
|
|
|
|
|
(975,000)
|
|
|
Convertible preferred stock dividend |
|
|
|
|
|
|
|
|
(3,625,000)
|
(2,145,000)
|
|
Payments of debt issuance costs |
|
|
|
|
|
|
|
|
(1,443,000)
|
|
|
Payment for noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
(3,375,000)
|
Payment of contingent consideration |
|
|
|
|
|
|
|
|
|
|
0
|
Shares surrendered in lieu of tax |
|
|
|
|
|
|
|
|
(251,000)
|
(936,000)
|
(1,156,000)
|
Intercompany advances, net |
|
|
|
|
|
|
|
|
48,594,000
|
21,101,000
|
154,687,000
|
Net cash provided by (used in) financing activities |
|
|
|
|
|
|
|
|
52,300,000
|
90,356,000
|
150,156,000
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
(59,048,000)
|
10,342,000
|
(8,985,000)
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|
75,342,000
|
|
|
|
65,000,000
|
75,342,000
|
65,000,000
|
73,985,000
|
Cash, cash equivalents and restricted cash at end of period |
16,294,000
|
|
|
|
75,342,000
|
|
|
|
16,294,000
|
75,342,000
|
65,000,000
|
Reportable Legal Entities | Guarantor |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
(54,508,000)
|
(1,655,000)
|
(48,922,000)
|
Adjustments to reconcile net income (loss): |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
76,353,000
|
81,248,000
|
90,197,000
|
(Gain) loss on debt modification |
|
|
|
|
|
|
|
|
|
|
0
|
Accretion on contingent consideration |
|
|
|
|
|
|
|
|
|
|
419,000
|
Gain (loss) on disposition of assets, net |
|
|
|
|
|
|
|
|
1,347,000
|
243,000
|
565,000
|
Deferred tax expense (benefit) |
|
|
|
|
|
|
|
|
(11,865,000)
|
(7,763,000)
|
14,940,000
|
Loss on impairment |
|
|
|
|
|
|
|
|
40,917,000
|
|
|
Equity in net earnings of subsidiaries |
|
|
|
|
|
|
|
|
0
|
|
|
Provision for reduction in carrying value of certain assets |
|
|
|
|
|
|
|
|
|
0
|
|
Expenses not requiring cash |
|
|
|
|
|
|
|
|
(302,000)
|
4,793,000
|
(4,900,000)
|
Equity in net earnings (losses) of subsidiaries |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Accounts and notes receivable |
|
|
|
|
|
|
|
|
(16,244,000)
|
(16,552,000)
|
25,848,000
|
Rig materials and supplies |
|
|
|
|
|
|
|
|
(4,454,000)
|
(1,869,000)
|
(361,000)
|
Other current assets |
|
|
|
|
|
|
|
|
(4,854,000)
|
34,096,000
|
(34,479,000)
|
Other non-current assets |
|
|
|
|
|
|
|
|
3,315,000
|
(1,542,000)
|
441,000
|
Accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
57,305,000
|
30,359,000
|
99,511,000
|
Accrued income taxes |
|
|
|
|
|
|
|
|
(10,415,000)
|
(61,233,000)
|
(1,134,000)
|
Net cash provided by (used in) operating activities |
|
|
|
|
|
|
|
|
76,595,000
|
60,125,000
|
142,125,000
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
|
|
|
|
|
|
(56,897,000)
|
(42,990,000)
|
(15,384,000)
|
Proceeds from the sale of assets |
|
|
|
|
|
|
|
|
87,000
|
68,000
|
437,000
|
Net cash provided by (used in) investing activities |
|
|
|
|
|
|
|
|
(56,810,000)
|
(42,922,000)
|
(14,947,000)
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the issuance of common stock |
|
|
|
|
|
|
|
|
|
0
|
|
Proceeds from the issuance of convertible preferred stock |
|
|
|
|
|
|
|
|
|
0
|
|
Payment of equity issuance costs |
|
|
|
|
|
|
|
|
|
0
|
|
Proceeds from borrowing under DIP facility |
|
|
|
|
|
|
|
|
0
|
|
|
Payment of DIP facility costs |
|
|
|
|
|
|
|
|
0
|
|
|
Convertible preferred stock dividend |
|
|
|
|
|
|
|
|
0
|
0
|
|
Payments of debt issuance costs |
|
|
|
|
|
|
|
|
0
|
|
|
Payment for noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
0
|
Payment of contingent consideration |
|
|
|
|
|
|
|
|
|
|
(6,000,000)
|
Shares surrendered in lieu of tax |
|
|
|
|
|
|
|
|
0
|
0
|
|
Intercompany advances, net |
|
|
|
|
|
|
|
|
(31,119,000)
|
(10,753,000)
|
(120,659,000)
|
Net cash provided by (used in) financing activities |
|
|
|
|
|
|
|
|
(31,119,000)
|
(10,753,000)
|
(126,659,000)
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
(11,334,000)
|
6,450,000
|
519,000
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|
20,655,000
|
|
|
|
14,205,000
|
20,655,000
|
14,205,000
|
13,686,000
|
Cash, cash equivalents and restricted cash at end of period |
9,321,000
|
|
|
|
20,655,000
|
|
|
|
9,321,000
|
20,655,000
|
14,205,000
|
Reportable Legal Entities | Non-Guarantor |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
(33,040,000)
|
(39,097,000)
|
(45,547,000)
|
Adjustments to reconcile net income (loss): |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
31,192,000
|
41,125,000
|
49,598,000
|
(Gain) loss on debt modification |
|
|
|
|
|
|
|
|
|
|
0
|
Accretion on contingent consideration |
|
|
|
|
|
|
|
|
|
|
0
|
Gain (loss) on disposition of assets, net |
|
|
|
|
|
|
|
|
377,000
|
2,608,000
|
1,048,000
|
Deferred tax expense (benefit) |
|
|
|
|
|
|
|
|
(1,790,000)
|
2,754,000
|
6,151,000
|
Loss on impairment |
|
|
|
|
|
|
|
|
9,781,000
|
|
|
Equity in net earnings of subsidiaries |
|
|
|
|
|
|
|
|
0
|
|
|
Provision for reduction in carrying value of certain assets |
|
|
|
|
|
|
|
|
|
1,938,000
|
|
Expenses not requiring cash |
|
|
|
|
|
|
|
|
(8,498,000)
|
4,869,000
|
(2,127,000)
|
Equity in net earnings (losses) of subsidiaries |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Accounts and notes receivable |
|
|
|
|
|
|
|
|
1,009,000
|
13,495,000
|
34,543,000
|
Rig materials and supplies |
|
|
|
|
|
|
|
|
5,296,000
|
6,579,000
|
(1,391,000)
|
Other current assets |
|
|
|
|
|
|
|
|
2,082,000
|
14,881,000
|
(13,677,000)
|
Other non-current assets |
|
|
|
|
|
|
|
|
8,763,000
|
3,234,000
|
3,755,000
|
Accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
7,207,000
|
(7,925,000)
|
2,011,000
|
Accrued income taxes |
|
|
|
|
|
|
|
|
(2,460,000)
|
(17,548,000)
|
5,093,000
|
Net cash provided by (used in) operating activities |
|
|
|
|
|
|
|
|
19,919,000
|
26,913,000
|
39,457,000
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
|
|
|
|
|
|
(13,670,000)
|
(11,543,000)
|
(13,570,000)
|
Proceeds from the sale of assets |
|
|
|
|
|
|
|
|
1,266,000
|
335,000
|
2,004,000
|
Net cash provided by (used in) investing activities |
|
|
|
|
|
|
|
|
(12,404,000)
|
(11,208,000)
|
(11,566,000)
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the issuance of common stock |
|
|
|
|
|
|
|
|
|
0
|
|
Proceeds from the issuance of convertible preferred stock |
|
|
|
|
|
|
|
|
|
0
|
|
Payment of equity issuance costs |
|
|
|
|
|
|
|
|
|
0
|
|
Proceeds from borrowing under DIP facility |
|
|
|
|
|
|
|
|
0
|
|
|
Payment of DIP facility costs |
|
|
|
|
|
|
|
|
0
|
|
|
Convertible preferred stock dividend |
|
|
|
|
|
|
|
|
0
|
0
|
|
Payments of debt issuance costs |
|
|
|
|
|
|
|
|
0
|
|
|
Payment for noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
0
|
Payment of contingent consideration |
|
|
|
|
|
|
|
|
|
|
0
|
Shares surrendered in lieu of tax |
|
|
|
|
|
|
|
|
0
|
0
|
|
Intercompany advances, net |
|
|
|
|
|
|
|
|
(19,691,000)
|
(10,639,000)
|
(34,028,000)
|
Net cash provided by (used in) financing activities |
|
|
|
|
|
|
|
|
(19,691,000)
|
(10,639,000)
|
(34,028,000)
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
(12,176,000)
|
5,066,000
|
(6,137,000)
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|
45,552,000
|
|
|
|
40,486,000
|
45,552,000
|
40,486,000
|
46,623,000
|
Cash, cash equivalents and restricted cash at end of period |
33,376,000
|
|
|
|
45,552,000
|
|
|
|
33,376,000
|
45,552,000
|
40,486,000
|
Eliminations |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
87,548,000
|
40,752,000
|
94,469,000
|
Adjustments to reconcile net income (loss): |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
(Gain) loss on debt modification |
|
|
|
|
|
|
|
|
|
|
0
|
Accretion on contingent consideration |
|
|
|
|
|
|
|
|
|
|
0
|
Gain (loss) on disposition of assets, net |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Deferred tax expense (benefit) |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Loss on impairment |
|
|
|
|
|
|
|
|
0
|
|
|
Equity in net earnings of subsidiaries |
|
|
|
|
|
|
|
|
0
|
|
|
Provision for reduction in carrying value of certain assets |
|
|
|
|
|
|
|
|
|
0
|
|
Expenses not requiring cash |
|
|
|
|
|
|
|
|
9,425,000
|
(11,062,000)
|
0
|
Equity in net earnings (losses) of subsidiaries |
|
|
|
|
|
|
|
|
(87,548,000)
|
(40,752,000)
|
(94,469,000)
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Accounts and notes receivable |
|
|
|
|
|
|
|
|
0
|
(6,571,000)
|
0
|
Rig materials and supplies |
|
|
|
|
|
|
|
|
(593,000)
|
0
|
0
|
Other current assets |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Other non-current assets |
|
|
|
|
|
|
|
|
(101,000)
|
6,605,000
|
0
|
Accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
(10,947,000)
|
10,737,000
|
0
|
Accrued income taxes |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Net cash provided by (used in) operating activities |
|
|
|
|
|
|
|
|
(2,216,000)
|
(291,000)
|
0
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Proceeds from the sale of assets |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Net cash provided by (used in) investing activities |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the issuance of common stock |
|
|
|
|
|
|
|
|
|
0
|
|
Proceeds from the issuance of convertible preferred stock |
|
|
|
|
|
|
|
|
|
0
|
|
Payment of equity issuance costs |
|
|
|
|
|
|
|
|
|
0
|
|
Proceeds from borrowing under DIP facility |
|
|
|
|
|
|
|
|
0
|
|
|
Payment of DIP facility costs |
|
|
|
|
|
|
|
|
0
|
|
|
Convertible preferred stock dividend |
|
|
|
|
|
|
|
|
0
|
0
|
|
Payments of debt issuance costs |
|
|
|
|
|
|
|
|
0
|
|
|
Payment for noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
0
|
Payment of contingent consideration |
|
|
|
|
|
|
|
|
|
|
0
|
Shares surrendered in lieu of tax |
|
|
|
|
|
|
|
|
0
|
0
|
|
Intercompany advances, net |
|
|
|
|
|
|
|
|
2,216,000
|
291,000
|
0
|
Net cash provided by (used in) financing activities |
|
|
|
|
|
|
|
|
2,216,000
|
291,000
|
0
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|
$ 0
|
|
|
|
$ 0
|
0
|
0
|
0
|
Cash, cash equivalents and restricted cash at end of period |
$ 0
|
|
|
|
$ 0
|
|
|
|
$ 0
|
$ 0
|
$ 0
|